OREF’s Orizon venture fund is funding a wide variety of technologies in musculoskeletal world.
In this brief exchange, Tiger Buford asks whether OREF’s Orizon venture fund is investing in cutting‑edge areas such as AI, genomics, and advanced imaging, or if it sticks to more traditional approaches. The responding speaker outlines the fund’s current interests, highlighting cellular technologies, biologics, robotics, patient registries, data collection, and AI as the primary drivers of future innovation in the musculoskeletal field. They also reference a recently completed grant led by Dr. Tom Ferring of North Carolina, which is slated for imminent publication, illustrating the fund’s active support of research initiatives.
More from Tiger
BoneChat #144 - Defining the Standard of Care for Orthopedic Tissue Preservation & Restoration
BoneChat #143 - AI-Driven MedTech Sales, Startup Traps, & Orthopedic Commercialization
BoneChat #142 - Fastest-Growing Ortho Segments, Reverse Shoulder & Joint Preservation Rollups
BoneChat #141 - Disrupting Surgical Visualization: Single-Use 4K Scopes with Richard McKillop
BoneChat #140 - Transforming Knee Rehab, Patient Experience, and MedTech Go-to-Market
